Health and Fitness Health and Fitness
Mon, August 22, 2011
[ Mon, Aug 22nd 2011 ] - Market Wire
Health Net Reminds California Parents, Schools about New Immunization Requirements
[ Mon, Aug 22nd 2011 ] - Market Wire
Enzo Biochem Appoints Four Executives at Enzo Lif .. ucts and Platforms to More Aggressively Expand in
[ Mon, Aug 22nd 2011 ] - Market Wire
Dendreon Announces Election of John H. Johnson to Board of Directors
[ Mon, Aug 22nd 2011 ] - Market Wire
Zynex, Inc. to Exhibit at MEDICA 2011-World Forum for Medicine International Trade Fair
[ Mon, Aug 22nd 2011 ] - Market Wire
Celldex Announces In Vivo Efficacy Data for CDX-1 .. ease Reported at International Complement Meeting
[ Mon, Aug 22nd 2011 ] - Market Wire
BRILINTAa" (ticagrelor) Tablets Now Available in .. rmacies for Patients with Acute Coronary Syndrome
[ Mon, Aug 22nd 2011 ] - Market Wire
Health Canada Approves INCIVEKa" (telaprevir) for People With Hepatitis C
[ Mon, Aug 22nd 2011 ] - Market Wire
MedPro Safety Products Reports on Second Quarter 2011 Progress and Recent Corporate Developments
[ Mon, Aug 22nd 2011 ] - Market Wire
Santarus and Depomed Announce New U.S. Commercial .. tion Agreement for GLUMETZA Prescription Products
Sat, August 20, 2011
[ Sat, Aug 20th 2011 ] - Market Wire
3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011
Fri, August 19, 2011
[ Fri, Aug 19th 2011 ] - Market Wire
Seattle Genetics Announces FDA Accelerated Approv .. ETRISa" (Brentuximab Vedotin) for Two Indications
[ Fri, Aug 19th 2011 ] - Market Wire
Humana Board Declares Payment of Quarterly Dividend to Stockholders
[ Fri, Aug 19th 2011 ] - Market Wire
Amyris assina contrato plurianual para fornecer esqualeno renovvel para a Nikko Chemicals
[ Fri, Aug 19th 2011 ] - Market Wire
Bring Home Upwards of $1 Trillion to Invest in Re .. nd Michael Klayko; Article in "The Hill" Calls fo
[ Fri, Aug 19th 2011 ] - Market Wire
Tibet Pharmaceuticals Announces Availability of Second Quarter 2011 Earnings Call Transcript
[ Fri, Aug 19th 2011 ] - Market Wire
Alexza Announces Adasuvea" (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
[ Fri, Aug 19th 2011 ] - Market Wire
Cannabis Science Signs Exclusive and Non-Exclusiv .. Vending Machines to Distribute its Patented Mari
Thu, August 18, 2011
[ Thu, Aug 18th 2011 ] - Market Wire
Positron Moves into New PosiRx Manufacturing Facility
[ Thu, Aug 18th 2011 ] - Market Wire
Medtronic Gains CE Mark for 31mm CoreValve® Percutaneous Aortic Valve
[ Thu, Aug 18th 2011 ] - Market Wire
Synergetics USA, Inc. to Present at the Midwest IDEAS Investor Conference
[ Thu, Aug 18th 2011 ] - Market Wire
Roche and PerkinElmer Enter into New Agreement fo .. tion of NimbleGen CGX Cytogenetics Array Workflow
[ Thu, Aug 18th 2011 ] - Market Wire
Celgene Announces Additional $2 Billion Share Repurchase Authorization
[ Thu, Aug 18th 2011 ] - Market Wire
Merck and ARIAD Announce European Medicines Agenc .. tion Application for Ridaforolimus, Investigation
[ Thu, Aug 18th 2011 ] - Market Wire
CELGENE anuncia autorizacin para la recompra de 2 mil millones de dlares de acciones adicionales
[ Thu, Aug 18th 2011 ] - Market Wire
Celgene anuncia a autorizao de mais US$2 bilhes adicionais para a recompra de aes.
[ Thu, Aug 18th 2011 ] - Market Wire
Winner Medical Granted the COTTON USA Mark
Wed, August 17, 2011
[ Wed, Aug 17th 2011 ] - Market Wire
Cord Blood America Enters Agreement With Premera .. Member Discount on Stem Cell Collection Services
[ Wed, Aug 17th 2011 ] - Market Wire
Endo Pharmaceuticals Announces Termination of Col .. n with Grunenthal for the Development of Axomadol
[ Wed, Aug 17th 2011 ] - Market Wire
PHC Announces 20.1% Increase in Fiscal 2011 Fourth Quarter Total Revenues
[ Wed, Aug 17th 2011 ] - Market Wire
Centric Health Completes Acquisition of Blue Wate .. cal, Windsor Endoscopy and London Scoping Centres
[ Wed, Aug 17th 2011 ] - Market Wire
Prism Medical Announces New UK Contracts with Anchor Trust
[ Wed, Aug 17th 2011 ] - Market Wire
PPD???????BioDuro?????
[ Wed, Aug 17th 2011 ] - Market Wire
International Stem Cell Corporation Announces Sec .. arter 2011 Financial Results and Corporate Events
[ Wed, Aug 17th 2011 ] - Market Wire
Allos Therapeutics Initiates Phase 3 Registration .. iagnosed Patients with Peripheral T-Cell Lymphoma
[ Wed, Aug 17th 2011 ] - Market Wire
Emergent Announces Initiation of a Phase 1b/2 Stu .. with Rituximab and Bendamustine in Subjects with
Tue, August 16, 2011
[ Tue, Aug 16th 2011 ] - Market Wire
BD Completes Acquisition of Carmel Pharma
[ Tue, Aug 16th 2011 ] - Market Wire
Abbott Receives FDA Approval for Two Three-Month .. � (leuprolide acetate for depot suspension) for t
[ Tue, Aug 16th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Dendreon Corp.
[ Tue, Aug 16th 2011 ] - Market Wire
El r©gimen Quad antirretroviral en fase de inves .. bjetivo principal de 48 semanas en el estudio 102
[ Tue, Aug 16th 2011 ] - Market Wire
A.M. Best Assigns Ratings to WellPoint Inc.a?s New Senior Unsecured Notes
[ Tue, Aug 16th 2011 ] - Market Wire
Derma Sciences Reports Second Quarter Operating Results
[ Tue, Aug 16th 2011 ] - Market Wire
Bond Labs Recaps Profitable and Successful 2nd Quarter
[ Tue, Aug 16th 2011 ] - Market Wire
POZEN Welcomes Clint Burrus as Vice President, Customer Development
[ Tue, Aug 16th 2011 ] - Market Wire
AngioDynamics Names Joseph M. DeVivo President and CEO
Mon, August 15, 2011
[ Mon, Aug 15th 2011 ] - Market Wire
ArthroCare® Receives FDA Clearance for SpeedLock® Knotless Fixation Device
[ Mon, Aug 15th 2011 ] - Market Wire
Angeion's Medical Graphics Business Awarded National Group Purchasing Contract by Novation
[ Mon, Aug 15th 2011 ] - Market Wire
American Medical Alert Corp. Reports Second Quarter 2011 Results
[ Mon, Aug 15th 2011 ] - Market Wire
West Expands Research and Development Center
[ Mon, Aug 15th 2011 ] - Market Wire
Bristol-Myers Squibb Announces the Winners of the .. (atazanavir sulfate) aFight HIV Your Waya Contest
[ Mon, Aug 15th 2011 ] - Market Wire
American Medical Alert Corp. Postpones Earnings Call
[ Mon, Aug 15th 2011 ] - Market Wire
Impax and GSK Announce Positive Topline Results o .. Study of IPX066 in Advanced Parkinsona?s Disease
[ Mon, Aug 15th 2011 ] - Market Wire
Acorda Therapeutics Joins NY BioHud Valley as Founding Member
Fri, August 12, 2011
[ Fri, Aug 12th 2011 ] - Market Wire
GeoVax Labs, Inc. Announces Second Quarter Financial Results
[ Fri, Aug 12th 2011 ] - Market Wire
Spherix Announces Second Quarter Financial Results
[ Fri, Aug 12th 2011 ] - Market Wire
Hagens Berman Reminds Investors of Deadline in Securities Class-Action Lawsuit against Dendreon
[ Fri, Aug 12th 2011 ] - Market Wire
IDC Reports Second Quarter 2011 Results
[ Fri, Aug 12th 2011 ] - Market Wire
Viropro, Inc. Retains Cooper Global Communications as Investor Relations Advisor
[ Fri, Aug 12th 2011 ] - Market Wire
Medtronic to Announce Financial Results for Its First Quarter of the Fiscal Year 2012
[ Fri, Aug 12th 2011 ] - Market Wire
Galectin Therapeutics Reports Financial Results for Second Quarter 2011
[ Fri, Aug 12th 2011 ] - Market Wire
Medical Facilities Corporation Reports 2011 Second Quarter Financial Results
Thu, August 11, 2011
[ Thu, Aug 11th 2011 ] - Market Wire
Covidien kondigt programma aan voor heraankoop van aandelen
[ Thu, Aug 11th 2011 ] - Market Wire
Repligen Announces Robert A. Spurr Joins Company .. Sales and Marketing and Chief Commercial Officer
[ Thu, Aug 11th 2011 ] - Market Wire
Forest Laboratories Sends Open Letter to Shareholders
[ Thu, Aug 11th 2011 ] - Market Wire
Aetna and the Aetna Foundation Granted $847,000 to California Nonprofits in 2010
[ Thu, Aug 11th 2011 ] - Market Wire
Gilead Sciences resuelve los asuntos pendientes d .. iada por la FDA en relacin con la planta de produ
[ Thu, Aug 11th 2011 ] - Market Wire
Theragenics Reports Record Revenue for Second Quarter and First Half of 2011
[ Thu, Aug 11th 2011 ] - Market Wire
Centric Health Reports Second Quarter Results
[ Thu, Aug 11th 2011 ] - Market Wire
Media Advisory - Oncolytics Biotech® Inc. to .. h 2011 Life Sciences Management Access Conference
Wed, August 10, 2011
[ Wed, Aug 10th 2011 ] - Market Wire
U.S. Food and Drug Administration Approves Gilead .. Complete Once-Daily, Single-Tablet Regimen for H
[ Wed, Aug 10th 2011 ] - Market Wire
Zalicus to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
[ Wed, Aug 10th 2011 ] - Market Wire
Nuvo Research Announces 2011 Second Quarter Results
[ Wed, Aug 10th 2011 ] - Market Wire
Synovis Life Technologies, Inc. Third-Quarter Conference Call
[ Wed, Aug 10th 2011 ] - Market Wire
Healthways Announces 5-Year Expansion and Extensi .. tionship with Wellmark Blue Cross and Blue Shield
[ Wed, Aug 10th 2011 ] - Market Wire
Isotechnika Pharma Inc. Appoints Daniel Park as Chief Business Officer
[ Wed, Aug 10th 2011 ] - Market Wire
Protox reports second quarter 2011 financial results and achievements
[ Wed, Aug 10th 2011 ] - Market Wire
Acorda Therapeutics Announces Allowance of Second .. MPYRA® Covering Methods of Use for Improving Wal
Tue, August 9, 2011
[ Tue, Aug 09th 2011 ] - Market Wire
ADVENTRX Receives Complete Response Letter for Exelbine NDA
[ Tue, Aug 09th 2011 ] - Market Wire
Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
[ Tue, Aug 09th 2011 ] - Market Wire
Masimo Announces Adoption of Stock Repurchase Program
[ Tue, Aug 09th 2011 ] - Market Wire
Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
[ Tue, Aug 09th 2011 ] - Market Wire
IMRIS Reports Solid Second Quarter 2011 Financial Results
[ Tue, Aug 09th 2011 ] - Market Wire
Boston Scientific, StanCorp Financial Group, Johnson & Johnson, Microsoft and Target
[ Tue, Aug 09th 2011 ] - Market Wire
Akela Pharma Announces New Strategic Focus on Profitable PharmaForm Division
[ Tue, Aug 09th 2011 ] - Market Wire
Phase 2 Trial of Lexicon's LX1032, Telotristat Et .. ate, Shows Positive Results in Carcinoid Syndrome
Mon, August 8, 2011
[ Mon, Aug 08th 2011 ] - Market Wire
Apricus Biosciences to File for Market Authorizat .. taros® for Erectile Dysfunction in Latin America
[ Mon, Aug 08th 2011 ] - Market Wire
Array Announces New Oncology Agreement with Genentech
[ Mon, Aug 08th 2011 ] - Market Wire
The CTLM is a New and Unique Imaging Technology B .. t Described as 'Diffuse Optical Tomography' (DOT)
[ Mon, Aug 08th 2011 ] - Market Wire
Exelixis Announces August 10th Webcast of Presentation at the Canaccord Genuity Growth Conference
[ Mon, Aug 08th 2011 ] - Market Wire
Unigene Reports Second Quarter 2011 Financial Results
[ Mon, Aug 08th 2011 ] - Market Wire
Abaxis Announces Stock Repurchase Program
[ Mon, Aug 08th 2011 ] - Market Wire
Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results
[ Mon, Aug 08th 2011 ] - Market Wire
China Medical Technologies and Leica Microsystems Announce Collaboration
Sun, August 7, 2011
[ Sun, Aug 07th 2011 ] - Market Wire
Bionovo Announces Second Quarter 2011 Highlights and Financial Results
Sat, August 6, 2011
[ Sat, Aug 06th 2011 ] - Market Wire
Universal American Approved for New Medicare Advantage Sales
[ Sat, Aug 06th 2011 ] - Market Wire
Forest Laboratories Issues Statement Regarding Litigation with Icahn
[ Sat, Aug 06th 2011 ] - Market Wire
Idera Pharmaceuticals Reports Second Quarter 2011 Financial Results
[ Sat, Aug 06th 2011 ] - Market Wire
Osiris Therapeutics Reports Second Quarter 2011 Financial Results
[ Sat, Aug 06th 2011 ] - Market Wire
Greatbatch, Inc. to Participate in the Canaccord Genuity Growth Conference
[ Sat, Aug 06th 2011 ] - Market Wire
HHS-OIG Drops Potential Action against Forest CEO Howard Solomon
Fri, August 5, 2011
[ Fri, Aug 05th 2011 ] - Market Wire
Bionovo Announces Second Quarter 2011 Highlights and Financial Results
[ Fri, Aug 05th 2011 ] - Market Wire
David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
[ Fri, Aug 05th 2011 ] - Market Wire
OncoGenex Pharmaceuticals, Inc. Reports Financial .. 011 and Provides Update on Development Activities
[ Fri, Aug 05th 2011 ] - Market Wire
Transcept Pharmaceuticals to Report Second Quarte .. ults, and Host Conference Call on August 11, 2011
[ Fri, Aug 05th 2011 ] - Market Wire
Delcath to Present at the Canaccord Genuity Growth Conference on August 9, 2011
[ Fri, Aug 05th 2011 ] - Market Wire
QIAGEN Completes Second U.S.Submission for Compan .. to Guide Treatment Decisions in Colorectal Cancer
[ Fri, Aug 05th 2011 ] - Market Wire
Amylin and Takeda Discontinue Development of Pram .. on Treatment for Obesity Following Commercial Rea
[ Fri, Aug 05th 2011 ] - Market Wire
Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2011 Financial Results
Thu, August 4, 2011
[ Thu, Aug 04th 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Second Quarter 2011 Financial and Operational Results
[ Thu, Aug 04th 2011 ] - Market Wire
Inhibitex to Present at the 2011 Canaccord Genuity Growth Conference on Tuesday, August 9th
[ Thu, Aug 04th 2011 ] - Market Wire
Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America
[ Thu, Aug 04th 2011 ] - Market Wire
Imris Receives Health Canada Approval for AccuTrack&;#8482;
[ Thu, Aug 04th 2011 ] - Market Wire
Labopharm Reports Financial Results for Second Quarter 2011
Wed, August 3, 2011
[ Wed, Aug 03rd 2011 ] - Market Wire
Kahn Swick & Foti, LLC Announces Investigation into Dendreon Corp.
[ Wed, Aug 03rd 2011 ] - Market Wire
Alliance HealthCare Services Receives National Ex .. nt Expectations Award for Fourth Consecutive Year
[ Wed, Aug 03rd 2011 ] - Market Wire
NPS Pharmaceuticals to Present at Canaccord Genuity Growth Conference
[ Wed, Aug 03rd 2011 ] - Market Wire
ImmunoGen, Inc. Reports Fourth Quarter and Fiscal .. and Provides Corporate Update and Fiscal Year 201
[ Wed, Aug 03rd 2011 ] - Market Wire
Merck e Serum Institute anunciam colaborao para d .. sso global Vacina Pneumoccica Conjugada (PCV pela
[ Wed, Aug 03rd 2011 ] - Market Wire
ImmunoCellular Therapeutics Issued New Patent for .. Treatment of Ovarian Cancer and Multiple Myeloma
[ Wed, Aug 03rd 2011 ] - Market Wire
Amyris Reports Second Quarter Financial Results
[ Wed, Aug 03rd 2011 ] - Market Wire
Oncolytics Biotech® Inc. to Present at 31st Canaccord Genuity Growth Conference
Tue, August 2, 2011
[ Tue, Aug 02nd 2011 ] - Market Wire
The Law Offices of Vincent Wong Announce an Investigation of Allied Healthcare International Inc.
[ Tue, Aug 02nd 2011 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of Allied Healthcare International Inc.
[ Tue, Aug 02nd 2011 ] - Market Wire
Brookdale Announces Completion of Financing Transaction
[ Tue, Aug 02nd 2011 ] - Market Wire
Sonomax announces first shipment of sculpted eers .. o Airport Wireless® &; Tech Showcase&;#8482;
[ Tue, Aug 02nd 2011 ] - Market Wire
Oncolytics Biotech® Inc. Announces Publicati .. Synergistic Combination of Chemotherapy with Onc
[ Tue, Aug 02nd 2011 ] - Market Wire
The Ensign Group Announces Acquisition of Texas City Skilled Nursing Facility
[ Tue, Aug 02nd 2011 ] - Market Wire
The Ensign Group Announces Expansion Into Southern Utah
[ Tue, Aug 02nd 2011 ] - Market Wire
The Ensign Group Acquires Dallas Assisted and Independent Living Facility
Mon, August 1, 2011
[ Mon, Aug 01st 2011 ] - Market Wire
American Medical Alert Corp. To Host Webcast on Second Quarter 2011 Results
[ Mon, Aug 01st 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. stigation of Allied Healthcare International Inc.
[ Mon, Aug 01st 2011 ] - Market Wire
Misonix Announces New Distribution Agreement for Chile
[ Mon, Aug 01st 2011 ] - Market Wire
Sunrise Addresses the Center for Medicare & Medic .. n for Skilled Nursing Facilities Beginning in Fis
[ Mon, Aug 01st 2011 ] - Market Wire
NanoViricides Expands On Prior HIVCide Effectiveness Release
[ Mon, Aug 01st 2011 ] - Market Wire
ZIOPHARM Reports Second Quarter Financial Results and Highlights
[ Mon, Aug 01st 2011 ] - Market Wire
IR Global Rankings Debuts in India - Registration .. erican Companies for the 2011 Edition Starts Toda
[ Mon, Aug 01st 2011 ] - Market Wire
Acorda Therapeutics Reports Second Quarter 2011 Financial Results
Sun, July 31, 2011
[ Sun, Jul 31st 2011 ] - Market Wire
Accuray Symposium Puts Spotlight on Quality Assur .. in Radiation Oncology at Joint AAPM/COMP Meeting
Fri, July 29, 2011
[ Fri, Jul 29th 2011 ] - Market Wire
Forest Laboratories Files Investor Presentation
[ Fri, Jul 29th 2011 ] - Market Wire
Aetna and the Aetna Foundation Granted $1.03 Million to Washington, D.C.-Based Nonprofits in 2010
[ Fri, Jul 29th 2011 ] - Market Wire
Aetna and the Aetna Foundation Partner with Atlanta-Area Nonprofits to Fight Obesity
[ Fri, Jul 29th 2011 ] - Market Wire
Fernando Aguirre to Join Aetna Board of Directors
[ Fri, Jul 29th 2011 ] - Market Wire
Law Firm Brower Piven Announces Investigation of Allied Healthcare International Inc.
[ Fri, Jul 29th 2011 ] - Market Wire
Notice of Medical Facilities Corporation';s 2011 Second Quarter Financial Results Conference Call
[ Fri, Jul 29th 2011 ] - Market Wire
Magellan Health Services Reports Second Quarter 2011 Financial Results
[ Fri, Jul 29th 2011 ] - Market Wire
Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
Thu, July 28, 2011
[ Thu, Jul 28th 2011 ] - Market Wire
Centric Health Announces Terms of Alegro Health Partners Transaction
[ Thu, Jul 28th 2011 ] - Market Wire
Icagen Stockholders Contest Proposed Acquisition Price by Pfizer in Letter to Board
[ Thu, Jul 28th 2011 ] - Market Wire
DaVita Offers Kidney-Friendly Recipes to Beat the Heat
[ Thu, Jul 28th 2011 ] - Market Wire
BioSante Pharmaceuticals Prices Public Offering of Common Stock
[ Thu, Jul 28th 2011 ] - Market Wire
POZEN Reports Second Quarter 2011 Results
[ Thu, Jul 28th 2011 ] - Market Wire
Amedisys Home Health Care Receives Pay-for-Performance Award from CMS
[ Thu, Jul 28th 2011 ] - Market Wire
GTx, Inc. To Host Second Quarter 2011 Financial Results Conference Call and Webcast
[ Thu, Jul 28th 2011 ] - Market Wire
Spectranetics Achieves Record Revenue of $32.2 Mi .. lion in Second Quarter, 7% Growth over Prior Year
Wed, July 27, 2011
[ Wed, Jul 27th 2011 ] - Market Wire
CytRx Prices $20.4 Million Public Offering
[ Wed, Jul 27th 2011 ] - Market Wire
Affymax and Takeda Announce FDA Acceptance of New Drug Application for Peginesatide
[ Wed, Jul 27th 2011 ] - Market Wire
POZEN Welcomes Dr. Seth A. Rudnick to the Board of Directors
[ Wed, Jul 27th 2011 ] - Market Wire
00 AM EDT
[ Wed, Jul 27th 2011 ] - Market Wire
Repligen Reports First Quarter Fiscal Year 2012 Financial Results
[ Wed, Jul 27th 2011 ] - Market Wire
Positive Data Demonstrating dermaPACE Safely Heal .. Highlighted in CME Presentation at the American P
[ Wed, Jul 27th 2011 ] - Market Wire
Columbia Laboratories Licenses STRIANT Canadian T .. Marketing Rights to Invaron Pharmaceuticals Inc.
[ Wed, Jul 27th 2011 ] - Market Wire
Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable
Tue, July 26, 2011
[ Tue, Jul 26th 2011 ] - Market Wire
Watson Enters into Agreement to Acquire Products .. to Perrigo's Acquisition of Paddock Laboratories
[ Tue, Jul 26th 2011 ] - Market Wire
Amyris to Supply Rio de Janeiro Buses with Renewable Diesel from Sugarcane
[ Tue, Jul 26th 2011 ] - Market Wire
Amyris Fornecer Diesel de Cana para "nibus no Rio de Janeiro
[ Tue, Jul 26th 2011 ] - Market Wire
American Anesthesiology Announces the Acquisition of Group Practice Based in Palm Beach County, FL
[ Tue, Jul 26th 2011 ] - Market Wire
Dyax Corp. and Kadmon Corporation Announce Antibody Library License Agreement
[ Tue, Jul 26th 2011 ] - Market Wire
Arrowhead Research Announces Oncology Expert Timo .. Triche to Join Calando Scientific Advisory Board
[ Tue, Jul 26th 2011 ] - Market Wire
Biogen Idec et Swedish Orphan Biovitrum pr©sente .. ement avec le facteur VIII recombinant action pro
[ Tue, Jul 26th 2011 ] - Market Wire
Biogen Idec und Swedish Orphan Biovitrum legen Da .. wirkenden rekombinanten Faktor VIII auf der Tagun
Mon, July 25, 2011
[ Mon, Jul 25th 2011 ] - Market Wire
Biogen Idec ontvangt voorwaardelijke goedkeuring .. RA® ter verbetering van het loopvermogen in volw
[ Mon, Jul 25th 2011 ] - Market Wire
Biogen Idec reoit un agr©ment conditionnel dans .. pour la?am©lioration de la mobilit© chez les p
[ Mon, Jul 25th 2011 ] - Market Wire
Response Genetics Announces Search for New CEO
[ Mon, Jul 25th 2011 ] - Market Wire
Celldex Therapeutics to Report Second Quarter 201 .. ts and Host Corporate 2011 Objectives Update Call
[ Mon, Jul 25th 2011 ] - Market Wire
Amyris and Firmenich Announce Expansion of Collaboration
[ Mon, Jul 25th 2011 ] - Market Wire
Amyris e Firmenich anunciam expanso de colaborao
[ Mon, Jul 25th 2011 ] - Market Wire
Illumina Announces First Customer Shipments of the Omni5 BeadChip
[ Mon, Jul 25th 2011 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Di .. Quarter 2011 Financial Results on August 1, 2011
Sat, July 23, 2011
[ Sat, Jul 23rd 2011 ] - Market Wire
Mettler-Toledo International Inc. to Webcast Investor Presentation
Fri, July 22, 2011
[ Fri, Jul 22nd 2011 ] - Market Wire
Watson Confirms JALYNa" Patent Challenge
[ Fri, Jul 22nd 2011 ] - Market Wire
Electromed, Inc. Names Diane M. Erdman as HR Director
[ Fri, Jul 22nd 2011 ] - Market Wire
30 p.m. ET to Discuss Financial Results for the Second Quarter and Six Months Ended June 30, 2011
[ Fri, Jul 22nd 2011 ] - Market Wire
Dr. Reddya?s Acquires Prescription Business of JB .. s & Pharmaceuticals in Russia & Other CIS Markets
[ Fri, Jul 22nd 2011 ] - Market Wire
International Drug & Explosives Detection Company .. From India for Drug Detectors and Explosive Ident
[ Fri, Jul 22nd 2011 ] - Market Wire
Centric Health to Acquire Majority Interest in Performance Medical Group
Thu, July 21, 2011
[ Thu, Jul 21st 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Jiangbo Pharmaceuticals, Inc.
[ Thu, Jul 21st 2011 ] - Market Wire
Fitch Upgrades Boston Scientific's IDR to 'BBB-'; Outlook to Stable
[ Thu, Jul 21st 2011 ] - Market Wire
Thermo Fisher Scientific Signs Agreement to Make .. iomarker Assays Available on Alere Triage Systems
[ Thu, Jul 21st 2011 ] - Market Wire
Elvitegravir antiretrovirale sperimentale di Gile .. a non inferiore a raltegravir due volte al giorno
[ Thu, Jul 21st 2011 ] - Market Wire
El antirretroviral en fase de investigacin de Gil .. da, no es inferior a raltegravir dos veces al da
[ Thu, Jul 21st 2011 ] - Market Wire
Gileada?s onderzoeks antiretroviraal elvitegravir .. erieur aan Raltegravir tweemaal daags na 48 weken
[ Thu, Jul 21st 2011 ] - Market Wire
Express Scripts and Medco Health Solutions Sign D .. ment; Medco Shareholders to Receive $29.1 Billion
[ Thu, Jul 21st 2011 ] - Market Wire
PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
Wed, July 20, 2011
[ Wed, Jul 20th 2011 ] - Market Wire
MURRAY FRANK LLP Investigates Allos Therapeutics, Inc.
[ Wed, Jul 20th 2011 ] - Market Wire
Robbins Umeda LLP Announces an Investigation of Allos Therapeutics, Inc.
[ Wed, Jul 20th 2011 ] - Market Wire
Obagi Medical Products to Present at the 31st Annual Canaccord Global Growth Conference
[ Wed, Jul 20th 2011 ] - Market Wire
Kindred Healthcare Announces Development of Inpatient Rehabilitation Hospitals
[ Wed, Jul 20th 2011 ] - Market Wire
FDA Approves New Medicine BRILINTAa" (ticagrelor) For Use in the US
[ Wed, Jul 20th 2011 ] - Market Wire
Covidien maakt contant kwartaaldividend bekend
[ Wed, Jul 20th 2011 ] - Market Wire
Idera Reports Clinical Hold on Proposed Phase 2 Clinical Trial of IMO-3100
[ Wed, Jul 20th 2011 ] - Market Wire
In der Erprobungsphase befindlicher Antiretrovira .. itegravir mit einmal tglicher Einahme, ist nach 4

NPS Pharmaceuticals to Present at Canaccord Genuity Growth Conference


//health-fitness.news-articles.net/content/2011/ .. sent-at-canaccord-genuity-growth-conference.html
Published in Health and Fitness on Wednesday, August 3rd 2011 at 20:01 GMT by Market Wire   Print publication without navigation


BEDMINSTER, N.J.--([ BUSINESS WIRE ])--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Canaccord Genuity 31st Annual Growth Conference in Boston on Tuesday, August 9, 2011 at 10:30 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the investorsa� calendar of events page on the NPS website at [ http://www.npsp.com/events ].

About NPS Pharmaceuticals

NPS Pharmaceuticals is an outsourcing-based development company focused on bringing biopharmaceuticals to patients with rare disorders and few, if any, therapeutic options. The company is advancing two Phase 3 registration programs, GATTEX� (teduglutide) in short bowel syndrome (SBS) and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) in hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical.


Publication Contributing Sources